IRCT20121110011424N4 IRCT 2019-05-08 Tehran University of Medical Sciences Melatonin in catamenial migraine headache compare with naproxen evaluation of melatonin efficacy on frequency and intensity of catamenial migraine headache comparing to naproxen 2018-08-28 anticipated 60 Complete https://irct.ir/trial/38209 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Factorial, Purpose: Prevention, Randomization description: Patients who had entry criteria were then randomly assigned to two groups by randomly assigned random access to the study type and the consent form for a group of melatonin and for the other naproxen. Patients and prescribing physicians They were unaware and the instructions for how to take the medication were also given to the patient, Blinding description: The person filling the questionnaire and analyzing the information and patients were unaware of the form of drug packaging and drug form, but the method of using the drug and other information needed by the person who delivered the drug to patients was explained to them. 2 Women with Catamenial migraine headache. Intervention 1: Intervention group: women with catamenial migraine treated with Naproxen. Intervention 2: Intervention group: women with catamenial migraine treated with Melatonin. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information